UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Monoclonal Antibody Therapies for High Risk Neuroblastoma

Biologics, 2021-01, Vol.15, p.205-219

Furman, Wayne L

2021

Volltextzugriff (PDF)

End-of-Life Care Preferences of Pediatric Patients With Cancer

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9146-9154

2005

Volltextzugriff (PDF)

Patients with retinoblastoma and chromosome 13q deletions have increased chemotherapy-related toxicities

Pediatric blood & cancer, 2016-11, Vol.63 (11), p.1954-1958

2016

Volltextzugriff (PDF)

Typhlitis in childhood cancer

Cancer, 2005-07, Vol.104 (2), p.380-387

2005

Volltextzugriff (PDF)

Vincristine/Irinotecan Upfront Window Treatment of High-risk Hepatoblastoma: A Report from the Children’s Oncology Group (COG) AHEP0731 Study Committee

Cancer, 2017-02, Vol.123 (12), p.2360-2367

2017

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Gefitinib in Children With Refractory Solid Tumors: A Children’s Oncology Group Study

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6172-6180

2005

Volltextzugriff (PDF)

Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors

Journal of pediatric hematology/oncology, 2015-01, Vol.37 (1), p.e13-e18

2015

Volltextzugriff (PDF)

Improved Response in High-Risk Neuroblastoma With Protracted Topotecan Administration Using a Pharmacokinetically Guided Dosing Approach

Journal of clinical oncology, 2005-06, Vol.23 (18), p.4039-4047

2005

Volltextzugriff (PDF)

Cefixime Allows Greater Dose Escalation of Oral Irinotecan: A Phase I Study in Pediatric Patients With Refractory Solid Tumors

Journal of clinical oncology, 2006-02, Vol.24 (4), p.563-570

2006

Volltextzugriff (PDF)

Direct Translation of a Protracted Irinotecan Schedule From a Xenograft Model to a Phase I Trial in Children

Journal of clinical oncology, 1999-06, Vol.17 (6), p.1815-1824

1999

Volltextzugriff (PDF)

The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma

Cancer, 2005-02, Vol.103 (4), p.780

2005

Volltextzugriff (PDF)

The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease : The St. Jude children's research hospital experience

Cancer, 2005-12, Vol.104 (12), p.2837-2846

2005

Volltextzugriff (PDF)

Evaluation of Gefitinib for Treatment of Refractory Solid Tumors and Central Nervous System Malignancies in Pediatric Patients

Cancer investigation, 2006-01, Vol.24 (3), p.310-317

2006

Volltextzugriff (PDF)

Combined Use of Erythropoietin and Granulocyte Colony-Stimulating Factor Does Not Decrease Blood Transfusion Requirements During Induction Therapy for High-Risk Neuroblastoma: A Randomized Controlled Trial

Journal of clinical oncology, 2004-05, Vol.22 (10), p.1886-1893

2004

Volltextzugriff (PDF)

Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas : The St. Jude children's research hospital experience

Cancer, 2006-04, Vol.106 (8), p.1846-1856

2006

Volltextzugriff (PDF)

Hypercalcemia complicating childhood malignancies

Cancer, 1993-07, Vol.72 (1), p.256-260

1993

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Topotecan Administered Orally Once Daily for 5 Days for 2 Consecutive Weeks to Pediatric Patients With Refractory Solid Tumors

Journal of clinical oncology, 2004-03, Vol.22 (5), p.829-837

2004

Volltextzugriff (PDF)

Phase I Trial of Tirapazamine and Cyclophosphamide in Children With Refractory Solid Tumors: A Pediatric Oncology Group Study

Journal of clinical oncology, 2004-04, Vol.22 (8), p.1413-1419

2004

Volltextzugriff (PDF)

11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia

Journal of clinical oncology, 1994-05, Vol.12 (5), p.909-915

1994

Volltextzugriff (PDF)

Protracted Intermittent Schedule of Topotecan in Children With Refractory Acute Leukemia: A Pediatric Oncology Group Study

Journal of clinical oncology, 2002-03, Vol.20 (6), p.1617-1624

Furman, W. L.

2002

Volltextzugriff (PDF)

Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy

Pediatric Blood & Cancer, 2005-02, Vol.44 (2), p.158-162

2005

Volltextzugriff (PDF)

Tumor recurrence at thoracostomy tube insertion sites: A report of two pediatric cases

Journal of pediatric surgery, 2004-10, Vol.39 (10), p.1565-1567

2004

Volltextzugriff (PDF)

CNS Involvement in Children With Newly Diagnosed Non-Hodgkin’s Lymphoma

Journal of clinical oncology, 2000-08, Vol.18 (16), p.3018-3024

2000

Volltextzugriff (PDF)

Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia

Journal of clinical oncology, 1996-05, Vol.14 (5), p.1504-1511

1996

Volltextzugriff (PDF)

Serum Interleukin 2 Receptor Levels in Childhood Acute Lymphoblastic Leukemia

Blood, 1988-04, Vol.71 (4), p.1135-1137

1988

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(79)

Sprache

Englisch
(79)

Erscheinungsjahr

n.n

Thema

Science & Technology
(74)
Life Sciences & Biomedicine
(73)
Humans
(70)
Child
(56)
Biological And Medical Sciences
(53)
Medical Sciences
(52)
Oncology
(52)
Male
(50)
Female
(49)
Child, Preschool
(47)
Adolescent
(46)
Infant
(35)
Adult
(29)
Pediatrics
(25)
Pharmacology. Drug Treatments
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Neoplasms - Drug Therapy
(15)
Tumors
(14)
Antineoplastic Agents
(13)
Prognosis
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Monoclonal Antibody Therapies for High Risk Neuroblastoma

End-of-Life Care Preferences of Pediatric Patients With Cancer

Patients with retinoblastoma and chromosome 13q deletions have increased chemotherapy-related toxicities

Typhlitis in childhood cancer

Vincristine/Irinotecan Upfront Window Treatment of High-risk Hepatoblastoma: A Report from the Children’s Oncology Group (COG) AHEP0731 Study Committee

Phase I and Pharmacokinetic Study of Gefitinib in Children With Refractory Solid Tumors: A Children’s Oncology Group Study

Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors

Improved Response in High-Risk Neuroblastoma With Protracted Topotecan Administration Using a Pharmacokinetically Guided Dosing Approach

Cefixime Allows Greater Dose Escalation of Oral Irinotecan: A Phase I Study in Pediatric Patients With Refractory Solid Tumors

Direct Translation of a Protracted Irinotecan Schedule From a Xenograft Model to a Phase I Trial in Children

The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma

The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease : The St. Jude children's research hospital experience

Evaluation of Gefitinib for Treatment of Refractory Solid Tumors and Central Nervous System Malignancies in Pediatric Patients

Combined Use of Erythropoietin and Granulocyte Colony-Stimulating Factor Does Not Decrease Blood Transfusion Requirements During Induction Therapy for High-Risk Neuroblastoma: A Randomized Controlled Trial

Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas : The St. Jude children's research hospital experience

Hypercalcemia complicating childhood malignancies

Phase I and Pharmacokinetic Study of Topotecan Administered Orally Once Daily for 5 Days for 2 Consecutive Weeks to Pediatric Patients With Refractory Solid Tumors

Phase I Trial of Tirapazamine and Cyclophosphamide in Children With Refractory Solid Tumors: A Pediatric Oncology Group Study

11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia

Protracted Intermittent Schedule of Topotecan in Children With Refractory Acute Leukemia: A Pediatric Oncology Group Study

Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy

Tumor recurrence at thoracostomy tube insertion sites: A report of two pediatric cases

CNS Involvement in Children With Newly Diagnosed Non-Hodgkin’s Lymphoma

Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia

Serum Interleukin 2 Receptor Levels in Childhood Acute Lymphoblastic Leukemia

Suchergebnisse filtern